14-day RSI
39.70
-2.41-5.72%
29 November 2024
Summary:
Viking Therapeutics stock 14-day relative strength index is 39.70, with the most recent change of -2.41 (-5.72%) on 29 November 2024. According to this value, VKTX stock is neither oversold nor overboughtVKTX RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | -5.7% | -3.0% | -0.5% | +0.2% |
| 1 m1 month | -34.0% | -28.0% | -2.0% | +6.4% |
| 3 m3 months | -28.5% | -15.6% | +11.7% | +28.1% |
| 6 m6 months | -3.4% | -16.5% | -12.5% | +79.4% |
| ytdytd | -35.6% | +189.7% | +360.6% | +296.5% |
| 1 y1 year | -31.0% | +353.7% | +474.4% | +314.9% |
| 5 y5 years | -21.2% | +622.7% | +796.0% | +699.8% |
VKTX RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 60.13 | -34.0% | 30.68 | +29.4% |
| 3 m | 3 months | 68.29 | -41.9% | 30.68 | +29.4% |
| 6 m | 6 months | 68.29 | -41.9% | 28.64 | +38.6% |
| 1 y | 1 year | 96.31 | -58.8% | 28.64 | +38.6% |
| 3 y | 3 years | 96.31 | -58.8% | 23.79 | +66.9% |
| 5 y | 5 years | 96.31 | -58.8% | 20.26 | +96.0% |
| alltime | all time | 96.31 | -58.8% | 13.61 | +191.7% |
Viking Therapeutics Stock RSI History
| Date | Value |
|---|---|
| 2024 | 39.70(-35.6%) |
| 2023 | 61.67(-29.0%) |
| 2022 | 86.86(+138.4%) |
| 2021 | 36.44(-0.4%) |
| 2020 | 36.60(-31.1%) |
| Date | Value |
|---|---|
| 2019 | 53.13(+54.9%) |
| 2018 | 34.30(-42.7%) |
| 2017 | 59.89(+3.7%) |
| 2016 | 57.78(+9.3%) |
| 2015 | 52.85 |
FAQ
- What is Viking Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Viking Therapeutics?
What is Viking Therapeutics 14-day relative strength index?
The current 14-day RSI of VKTX is 39.70
What is the all time high 14-day RSI for Viking Therapeutics?
Viking Therapeutics all-time high 14-day relative strength index is 96.31